Michael A. Gorin, MD, presented “Crossing the Divide from Transrectal to Transperineal Biopsy” for the Grand Rounds in Urology audience in June, 2020.
Michael A. Gorin, MD, a urologist at Urology Associates of Cumberland, Maryland, and Director of Medical Affairs for Perineologic, discusses the benefits of transperineal prostate biopsy over transrectal biopsy. He notes that transrectal prostate biopsy leads to infections in 5-7% of patients, and hospitalization in 1-3%, and argues that, of the three recommended methods for avoiding infection, which includes antibiotic augmentation, targeted prophylaxis, and transperineal biopsy, only transperineal biopsy avoids the problem of resistant bacteria. Transperineal biopsy also allows for better sampling of anterior tumors and a higher detection rate than does transrectal biopsy. Dr. Gorin acknowledges that the traditional use of a grid-stepper unit for performing transperineal biopsy can be very uncomfortable for patients, but suggests that new technology and techniques like the PrecisionPoint™ Transperineal Access System solve many of the discomfort issues.
Disclosures: Dr. Gorin is a consultant for Perineologic.
Q&A – Summary:
E. David Crawford, MD, interviews Michael A. Gorin, MD, on advances in transperineal prostate biopsy. When asked to predict what percentage of prostate biopsies will be performed transperineally in a year, Dr. Gorin opines that wider adoption of the technique will require a new insurance code, since it is currently billed under the same code as transrectal biopsy and doctors are therefore less well-compensated. Drs. Gorin and Crawford then discuss a new 3DBiopsy™ variable-length needle currently in development that Dr. Gorin suggests is critical for both transrectal and transperineal biopsy since it will allow urologists to take longer cores. Dr. Gorin concludes by affirming his commitment to teaching fellow urologists about transperineal biopsy.
How to cite: Gorin, Michael A. “Crossing the Divide from Transrectal to Transperineal Biopsy” June, 2020. Accessed Jul 2020. https://grandroundsinurology.com/managing-prostate-cancer-patients-and-lhrh-injection-times-during-covid-19/